Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 168

1.

Francisella tularensis: FupA mutation contributes to fluoroquinolone resistance by increasing vesicle secretion and biofilm formation.

Siebert C, Lindgren H, Ferré S, Villers C, Boisset S, Perard J, Sjöstedt A, Maurin M, Brochier-Armanet C, Couté Y, Renesto P.

Emerg Microbes Infect. 2019;8(1):808-822. doi: 10.1080/22221751.2019.1615848.

2.

Phospholipid levels in blood during community-acquired pneumonia.

Müller DC, Kauppi A, Edin A, Gylfe Å, Sjöstedt AB, Johansson A.

PLoS One. 2019 May 7;14(5):e0216379. doi: 10.1371/journal.pone.0216379. eCollection 2019.

3.

ClpB mutants of Francisella tularensis subspecies holarctica and tularensis are defective for type VI secretion and intracellular replication.

Alam A, Golovliov I, Javed E, Sjöstedt A.

Sci Rep. 2018 Jul 27;8(1):11324. doi: 10.1038/s41598-018-29745-4.

4.

Characterization of clinically relevant model bacterial strains of Pseudomonas aeruginosa for anti-biofilm testing of materials.

Rzhepishevska O, Limanska N, Galkin M, Lacoma A, Lundquist M, Sokol D, Hakobyan S, Sjöstedt A, Prat C, Ramstedt M.

Acta Biomater. 2018 Aug;76:99-107. doi: 10.1016/j.actbio.2018.06.019. Epub 2018 Jun 12.

PMID:
29902594
5.

Vaccine-Mediated Mechanisms Controlling Replication of Francisella tularensis in Human Peripheral Blood Mononuclear Cells Using a Co-culture System.

Eneslätt K, Golovliov I, Rydén P, Sjöstedt A.

Front Cell Infect Microbiol. 2018 Feb 7;8:27. doi: 10.3389/fcimb.2018.00027. eCollection 2018.

6.

Francisella noatunensis subspecies noatunensis clpB deletion mutant impairs development of francisellosis in a zebrafish model.

Lampe EO, Zingmark C, Tandberg JI, Thrane IMP, Brudal E, Sjöstedt A, Winther-Larsen HC.

Vaccine. 2017 Dec 19;35(52):7264-7272. doi: 10.1016/j.vaccine.2017.11.009. Epub 2017 Nov 16.

7.

IFN-γ extends the immune functions of Guanylate Binding Proteins to inflammasome-independent antibacterial activities during Francisella novicida infection.

Wallet P, Benaoudia S, Mosnier A, Lagrange B, Martin A, Lindgren H, Golovliov I, Michal F, Basso P, Djebali S, Provost A, Allatif O, Meunier E, Broz P, Yamamoto M, Py BF, Faudry E, Sjöstedt A, Henry T.

PLoS Pathog. 2017 Oct 2;13(10):e1006630. doi: 10.1371/journal.ppat.1006630. eCollection 2017 Oct.

8.

The Role and Mechanism of Erythrocyte Invasion by Francisella tularensis.

Schmitt DM, Barnes R, Rogerson T, Haught A, Mazzella LK, Ford M, Gilson T, Birch JW, Sjöstedt A, Reed DS, Franks JM, Stolz DB, Denvir J, Fan J, Rekulapally S, Primerano DA, Horzempa J.

Front Cell Infect Microbiol. 2017 May 9;7:173. doi: 10.3389/fcimb.2017.00173. eCollection 2017.

9.

Lack of OxyR and KatG Results in Extreme Susceptibility of Francisella tularensis LVS to Oxidative Stress and Marked Attenuation In vivo.

Honn M, Lindgren H, Bharath GK, Sjöstedt A.

Front Cell Infect Microbiol. 2017 Jan 24;7:14. doi: 10.3389/fcimb.2017.00014. eCollection 2017.

10.

An In Vitro Co-culture Mouse Model Demonstrates Efficient Vaccine-Mediated Control of Francisella tularensis SCHU S4 and Identifies Nitric Oxide as a Predictor of Efficacy.

Golovliov I, Lindgren H, Eneslätt K, Conlan W, Mosnier A, Henry T, Sjöstedt A.

Front Cell Infect Microbiol. 2016 Nov 25;6:152. eCollection 2016.

11.

A mutagenesis-based approach identifies amino acids in the N-terminal part of Francisella tularensis IglE that critically control Type VI system-mediated secretion.

Bröms JE, Meyer L, Sjöstedt A.

Virulence. 2017 Aug 18;8(6):821-847. doi: 10.1080/21505594.2016.1258507. Epub 2016 Nov 10.

12.

High-risk regions and outbreak modelling of tularemia in humans.

Desvars-Larrive A, Liu X, Hjertqvist M, Sjöstedt A, Johansson A, Rydén P.

Epidemiol Infect. 2017 Feb;145(3):482-490. doi: 10.1017/S0950268816002478. Epub 2016 Nov 3.

PMID:
27806741
13.

Francisella tularensis IglG Belongs to a Novel Family of PAAR-Like T6SS Proteins and Harbors a Unique N-terminal Extension Required for Virulence.

Rigard M, Bröms JE, Mosnier A, Hologne M, Martin A, Lindgren L, Punginelli C, Lays C, Walker O, Charbit A, Telouk P, Conlan W, Terradot L, Sjöstedt A, Henry T.

PLoS Pathog. 2016 Sep 7;12(9):e1005821. doi: 10.1371/journal.ppat.1005821. eCollection 2016 Sep.

14.

Phenotypic characterization of the Francisella tularensis ΔpdpC and ΔiglG mutants.

Ozanic M, Marecic V, Lindgren M, Sjöstedt A, Santic M.

Microbes Infect. 2016 Dec;18(12):768-776. doi: 10.1016/j.micinf.2016.07.006. Epub 2016 Jul 29.

PMID:
27477000
15.

Metabolites in Blood for Prediction of Bacteremic Sepsis in the Emergency Room.

Kauppi AM, Edin A, Ziegler I, Mölling P, Sjöstedt A, Gylfe Å, Strålin K, Johansson A.

PLoS One. 2016 Jan 22;11(1):e0147670. doi: 10.1371/journal.pone.0147670. eCollection 2016.

16.

Reclassification of Wolbachia persica as Francisella persica comb. nov. and emended description of the family Francisellaceae.

Larson MA, Nalbantoglu U, Sayood K, Zentz EB, Cer RZ, Iwen PC, Francesconi SC, Bishop-Lilly KA, Mokashi VP, Sjöstedt A, Hinrichs SH.

Int J Syst Evol Microbiol. 2016 Mar;66(3):1200-1205. doi: 10.1099/ijsem.0.000855. Epub 2016 Jan 7.

PMID:
26747442
17.

Dissection of Francisella-Host Cell Interactions in Dictyostelium discoideum.

Lampe EO, Brenz Y, Herrmann L, Repnik U, Griffiths G, Zingmark C, Sjöstedt A, Winther-Larsen HC, Hagedorn M.

Appl Environ Microbiol. 2015 Dec 28;82(5):1586-1598. doi: 10.1128/AEM.02950-15.

18.

Gallium Potentiates the Antibacterial Effect of Gentamicin against Francisella tularensis.

Lindgren H, Sjöstedt A.

Antimicrob Agents Chemother. 2015 Oct 26;60(1):288-95. doi: 10.1128/AAC.01240-15. Print 2016 Jan.

19.

Microinjection of Francisella tularensis and Listeria monocytogenes reveals the importance of bacterial and host factors for successful replication.

Meyer L, Bröms JE, Liu X, Rottenberg ME, Sjöstedt A.

Infect Immun. 2015 Aug;83(8):3233-42. doi: 10.1128/IAI.00416-15. Epub 2015 Jun 1.

20.

Roles of reactive oxygen species-degrading enzymes of Francisella tularensis SCHU S4.

Binesse J, Lindgren H, Lindgren L, Conlan W, Sjöstedt A.

Infect Immun. 2015 Jun;83(6):2255-63. doi: 10.1128/IAI.02488-14. Epub 2015 Mar 23.

21.

Development and laboratory evaluation of a real-time PCR assay for detecting viruses and bacteria of relevance for community-acquired pneumonia.

Edin A, Granholm S, Koskiniemi S, Allard A, Sjöstedt A, Johansson A.

J Mol Diagn. 2015 May;17(3):315-24. doi: 10.1016/j.jmoldx.2015.01.005. Epub 2015 Mar 13.

PMID:
25772704
22.

Mechanisms of heme utilization by Francisella tularensis.

Lindgren H, Lindgren L, Golovliov I, Sjöstedt A.

PLoS One. 2015 Mar 10;10(3):e0119143. doi: 10.1371/journal.pone.0119143. eCollection 2015.

23.

Epidemiology and ecology of tularemia in Sweden, 1984-2012.

Desvars A, Furberg M, Hjertqvist M, Vidman L, Sjöstedt A, Rydén P, Johansson A.

Emerg Infect Dis. 2015 Jan;21(1):32-9. doi: 10.3201/eid2101.140916.

24.

Climate change and infectious diseases in the Arctic: establishment of a circumpolar working group.

Parkinson AJ, Evengard B, Semenza JC, Ogden N, Børresen ML, Berner J, Brubaker M, Sjöstedt A, Evander M, Hondula DM, Menne B, Pshenichnaya N, Gounder P, Larose T, Revich B, Hueffer K, Albihn A.

Int J Circumpolar Health. 2014 Sep 30;73:25163. doi: 10.3402/ijch.v73.25163. eCollection 2014. Review.

25.

Identification of mechanisms for attenuation of the FSC043 mutant of Francisella tularensis SCHU S4.

Lindgren M, Tancred L, Golovliov I, Conlan W, Twine SM, Sjöstedt A.

Infect Immun. 2014 Sep;82(9):3622-35. doi: 10.1128/IAI.01406-13. Epub 2014 Jun 16.

26.

Screening for inhibition of Vibrio cholerae VipA-VipB interaction identifies small-molecule compounds active against type VI secretion.

Sun K, Bröms J, Lavander M, Gurram BK, Enquist PA, Andersson CD, Elofsson M, Sjöstedt A.

Antimicrob Agents Chemother. 2014 Jul;58(7):4123-30. doi: 10.1128/AAC.02819-13. Epub 2014 May 5.

27.

Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS).

De Pascalis R, Chou AY, Ryden P, Kennett NJ, Sjöstedt A, Elkins KL.

MBio. 2014 Apr 8;5(2):e00936. doi: 10.1128/mBio.00936-13.

28.

A ΔclpB mutant of Francisella tularensis subspecies holarctica strain, FSC200, is a more effective live vaccine than F. tularensis LVS in a mouse respiratory challenge model of tularemia.

Golovliov I, Twine SM, Shen H, Sjostedt A, Conlan W.

PLoS One. 2013 Nov 13;8(11):e78671. doi: 10.1371/journal.pone.0078671. eCollection 2013.

29.

A functional VipA-VipB interaction is required for the type VI secretion system activity of Vibrio cholerae O1 strain A1552.

Bröms JE, Ishikawa T, Wai SN, Sjöstedt A.

BMC Microbiol. 2013 May 3;13:96. doi: 10.1186/1471-2180-13-96.

30.

Importance of PdpC, IglC, IglI, and IglG for modulation of a host cell death pathway induced by Francisella tularensis.

Lindgren M, Eneslätt K, Bröms JE, Sjöstedt A.

Infect Immun. 2013 Jun;81(6):2076-84. doi: 10.1128/IAI.00275-13. Epub 2013 Mar 25.

31.

The Francisella tularensis LVS ΔpdpC mutant exhibits a unique phenotype during intracellular infection.

Lindgren M, Bröms JE, Meyer L, Golovliov I, Sjöstedt A.

BMC Microbiol. 2013 Jan 29;13:20. doi: 10.1186/1471-2180-13-20.

32.
33.

Unique substrates secreted by the type VI secretion system of Francisella tularensis during intramacrophage infection.

Bröms JE, Meyer L, Sun K, Lavander M, Sjöstedt A.

PLoS One. 2012;7(11):e50473. doi: 10.1371/journal.pone.0050473. Epub 2012 Nov 20.

34.

Link between intraphagosomal biotin and rapid phagosomal escape in Francisella.

Napier BA, Meyer L, Bina JE, Miller MA, Sjöstedt A, Weiss DS.

Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):18084-9. doi: 10.1073/pnas.1206411109. Epub 2012 Oct 15.

35.

Francisella is sensitive to insect antimicrobial peptides.

Vonkavaara M, Pavel ST, Hölzl K, Nordfelth R, Sjöstedt A, Stöven S.

J Innate Immun. 2013;5(1):50-9. doi: 10.1159/000342468. Epub 2012 Sep 29.

37.

DotU and VgrG, core components of type VI secretion systems, are essential for Francisella LVS pathogenicity.

Bröms JE, Meyer L, Lavander M, Larsson P, Sjöstedt A.

PLoS One. 2012;7(4):e34639. doi: 10.1371/journal.pone.0034639. Epub 2012 Apr 13.

38.
39.

Signatures of T cells as correlates of immunity to Francisella tularensis.

Eneslätt K, Normark M, Björk R, Rietz C, Zingmark C, Wolfraim LA, Stöven S, Sjöstedt A.

PLoS One. 2012;7(3):e32367. doi: 10.1371/journal.pone.0032367. Epub 2012 Mar 6.

40.

The role of MglA for adaptation to oxidative stress of Francisella tularensis LVS.

Honn M, Lindgren H, Sjöstedt A.

BMC Microbiol. 2012 Jan 21;12:14. doi: 10.1186/1471-2180-12-14.

41.

Outbreaks of tularemia in a boreal forest region depends on mosquito prevalence.

Rydén P, Björk R, Schäfer ML, Lundström JO, Petersén B, Lindblom A, Forsman M, Sjöstedt A, Johansson A.

J Infect Dis. 2012 Jan 15;205(2):297-304. doi: 10.1093/infdis/jir732. Epub 2011 Nov 28.

42.

Pathoadaptive conditional regulation of the type VI secretion system in Vibrio cholerae O1 strains.

Ishikawa T, Sabharwal D, Bröms J, Milton DL, Sjöstedt A, Uhlin BE, Wai SN.

Infect Immun. 2012 Feb;80(2):575-84. doi: 10.1128/IAI.05510-11. Epub 2011 Nov 14.

43.

The antibacterial activity of Ga3+ is influenced by ligand complexation as well as the bacterial carbon source.

Rzhepishevska O, Ekstrand-Hammarström B, Popp M, Björn E, Bucht A, Sjöstedt A, Antti H, Ramstedt M.

Antimicrob Agents Chemother. 2011 Dec;55(12):5568-80. doi: 10.1128/AAC.00386-11. Epub 2011 Sep 26.

44.

Immunoproteomic analysis of the human antibody response to natural tularemia infection with Type A or Type B strains or LVS vaccination.

Fulton KM, Zhao X, Petit MD, Kilmury SL, Wolfraim LA, House RV, Sjostedt A, Twine SM.

Int J Med Microbiol. 2011 Nov;301(7):591-601. doi: 10.1016/j.ijmm.2011.07.002. Epub 2011 Aug 27.

45.

Special Topic on Francisella tularensis and Tularemia.

Sjöstedt A.

Front Microbiol. 2011 Apr 25;2:86. doi: 10.3389/fmicb.2011.00086. eCollection 2011. No abstract available.

46.

Administration of a nitric oxide donor inhibits mglA expression by intracellular Francisella tularensis and counteracts phagosomal escape and subversion of TNF-α secretion.

Tancred L, Telepnev MV, Golovliov I, Andersson B, Andersson H, Lindgren H, Sjöstedt A.

J Med Microbiol. 2011 Nov;60(Pt 11):1570-83. doi: 10.1099/jmm.0.032870-0. Epub 2011 Jun 23.

PMID:
21700740
47.

IglG and IglI of the Francisella pathogenicity island are important virulence determinants of Francisella tularensis LVS.

Bröms JE, Lavander M, Meyer L, Sjöstedt A.

Infect Immun. 2011 Sep;79(9):3683-96. doi: 10.1128/IAI.01344-10. Epub 2011 Jun 20.

48.

Coagulase-negative staphylococci: update on the molecular epidemiology and clinical presentation, with a focus on Staphylococcus epidermidis and Staphylococcus saprophyticus.

Widerström M, Wiström J, Sjöstedt A, Monsen T.

Eur J Clin Microbiol Infect Dis. 2012 Jan;31(1):7-20. doi: 10.1007/s10096-011-1270-6. Epub 2011 May 1. Review.

PMID:
21533877
49.

Persistence of cell-mediated immunity three decades after vaccination with the live vaccine strain of Francisella tularensis.

Eneslätt K, Rietz C, Rydén P, Stöven S, House RV, Wolfraim LA, Tärnvik A, Sjöstedt A.

Eur J Immunol. 2011 Apr;41(4):974-80. doi: 10.1002/eji.201040923. Epub 2011 Feb 21.

50.

Cellular and molecular response of human macrophages exposed to Aggregatibacter actinomycetemcomitans leukotoxin.

Kelk P, Abd H, Claesson R, Sandström G, Sjöstedt A, Johansson A.

Cell Death Dis. 2011 Mar 10;2:e126. doi: 10.1038/cddis.2011.6.

Supplemental Content

Loading ...
Support Center